Gilead’s NASH combination treatment fails main goal of mid-stage study
Gilead Sciences Inc said on Monday all combinations of its three drugs to treat non-alcoholic steatohepatitis (NASH)failed to meet the main goal of a mid-stage...
Oil prices hold near three-month highs on U.S.-China trade deal
Oil prices held near three-month highs on Monday, supported by last week’s announcement of an initial trade deal between the United States and China....
Volvo Cars refinances $500 million worth of preference shares with Swedish investors
Chinese-owned Volvo Cars said on Monday it had sold 5 billion Swedish crowns ($519 million) of convertible preference shares to a group of Swedish investors...
Boeing suppliers bracing for temporary halt in 737 MAX output
Boeing suppliers, customers and financiers braced on Monday for a possible freeze in Boeing 737 production for the first time in more than 20 years...
Futures gain as initial U.S.-China trade deal cools tensions; Boeing dips
U.S. stock index futures rose on Monday as the top U.S. trade negotiator said a deal would nearly double exports to Beijing over the next...
WPX Energy to buy Delaware basin operator Felix in $2.5 billion deal
U.S. oil and gas producer WPX Energy Inc said on Monday it would buy privately held Felix Energy in a $2.5 billion deal, adding acreage...
Trump poised to become third U.S. president to be impeached
Republican Donald Trump is likely this week to become the third U.S. president to be impeached when the Democratic-led House of Representatives votes on charges...
From tweet to street: New generation joins Thai protest
It wasn’t only the moves to ban Thailand’s most vocal opposition party that brought Gift onto the street for the first time....
Costco in Caracas: how Florida goods flood Venezuelan stores
While U.S. President Donald Trump wants to drive Venezuela’s socialist ruler out of power with economic sanctions, there has in fact been a burgeoning influx...
BeiGene drug fails comparative study against AbbVie: J&J rival Imbruvica
BeiGene Ltd said on Monday a late-stage trial showed that its cancer treatment did not meet the main goal of proving superior to Imbruvica, a...